Á lódáil...

In Vivo and In Vitro Ivacaftor Response in Cystic Fibrosis Patients With Residual CFTR Function: N-of-1 Studies

Rationale: Ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, decreases sweat chloride concentration, and improves pulmonary function in 6% of cystic fibrosis (CF) patients with specific CFTR mutations. Ivacaftor increases chloride transport in many other CFTR mutat...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Pediatr Pulmonol
Main Authors: McGarry, Meghan E., Illek, Beate, Ly, Ngoc P., Zlock, Lorna, Olshansky, Sabrina, Moreno, Courtney, Finkbeiner, Walter E., Nielson, Dennis W.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2017
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461115/
https://ncbi.nlm.nih.gov/pubmed/28068001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.23659
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!